100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
Test Bank - Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition (Woo, 2024), Chapter 1-57 | All Chapters |complete Guide A+. CA$25.77   Add to cart
Quickly navigate to
Preview
  2.  
  3. Pharmacotherapeutics For Advanced Practice Nurse
  4.  
  5. Pharmacotherapeutics For Advanced Practice Nurse

Exam (elaborations)

Test Bank - Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition (Woo, 2024), Chapter 1-57 | All Chapters |complete Guide A+.
 32 views  1 purchase
  • Course
  • Pharmacotherapeutics For Advanced Practice Nurse
  • Institution
  • Pharmacotherapeutics For Advanced Practice Nurse
  • Book
  • Pharmacotherapeutics for Advanced Practice Nurse Prescribers

Test Bank - Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition (Woo, 2024), Chapter 1-57 | All Chapters |complete Guide A+.Test Bank - Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition (Woo, 2024), Chapter 1-57 | All Chapters |complete Guide A+.Test Ba...

[Show more]

Preview 4 out of 214  pages

Document information

  • September 24, 2024
  • 214
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers

Subjects

  • test bank pharmacotherapeutics for advanced prac
  • pharmacotherapeutics for advanced practice nurse
  • test bank pharmacotherapeutics for advanced prac

Connected book

book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:

More summaries for

  • TEST BANK For Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Woo & Wright, ISBN13: 9781719648035, All 57 Chapters Covered, Verified Latest Edition
  • Test Bank For Pharmacotherapeutics for Advanced Practice Nurse Prescribers 6th Edition By Teri Moser Woo, Wendy Wright (All Chapters, 100% Original Verified, A+ Grade)
  • TEST BANK For Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Woo & Wright|BEST STUDY
All for this textbook (48)

Written for

  • Pharmacotherapeutics For Advanced Practice Nurse
  • Pharmacotherapeutics For Advanced Practice Nurse

Seller

avatar-seller
DREAMS

Reviews received

Content preview

,Test Bank Pharmacotherapeutics forAdvanced Practice Nurse
i.l i.l i.l i.l i.l i.l




Prescribers 6e Teri Moser Woo
i.l i.l i.l i.l i.l




Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l




MULTIPLE CHOICE i.l




1. Nurse practitioner prescriptive authority is regulated by:
i.l i.l i.l i.l i.l i.l



A. The National Council of State Boards of Nursing i.l i.l i.l i.l i.l i.l i.l



B. The U.S. Drug Enforcement Administration i.l i.l i.l i.l



C. The State Board of Nursing for each state i.l i.l i.l i.l i.l i.l i.l



D. The State Board of Pharmacy i.l i.l i.l i.l




ANS: i . l C PTS: i . l 1

2. The benefits to the patient of having an advanced practice registered nurse (APRN)
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



prescriberinclude:
i.l i.l



A. Nurses know more about pharmacology than other prescribers because they take
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



itboth in their basic nursing program and in their APRN program.
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



B. Nurses care for the patient from a holistic approach and include the patient
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



indecision-making regarding their care.
i.l i.l i.l i.l i.l



C. APRNs are less likely to prescribe narcotics and other controlled substances. i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



D. APRNs are able to prescribe independently in all states, whereas a i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



physician’sassistant needs to have a physician supervising their practice.
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l




ANS: i . l B PTS: i . l 1

3. Clinical judgment in prescribing includes: i.l i.l i.l i.l



A. Factoring in the cost to the patient of the medication prescribed i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



B. Always prescribing the newest medication available for the disease process i.l i.l i.l i.l i.l i.l i.l i.l i.l



C. Handing out drug samples to poor patients i.l i.l i.l i.l i.l i.l



D. Prescribing all generic medications to cut costs i.l i.l i.l i.l i.l i.l




ANS: i . l A PTS: i . l 1

4. The process for choosing an effective drug for a disorder includes:
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



A. Asking the patient what drug they think would work best for them i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



B. Consulting nationally recognized guidelines for disease management i.l i.l i.l i.l i.l i.l



C. Prescribing medications that are available as samples before writing a prescription i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



D. Following U.S. Drug Enforcement Administration guidelines for prescribing i.l i.l i.l i.l i.l i.l i.l




ANS: i . l B PTS: i . l 1

5. Nonintentional nonadherence of drug therapy may occur due to: i.l i.l i.l i.l i.l i.l i.l i.l



A. Belief that medication does not work i.l i.l i.l i.l i.l



B. Adverse drug reactions i.l i.l



C. Chronic conditions that require daily therapy i.l i.l i.l i.l i.l



D. Forgetfulness or distraction i.l i.l




ANS: i . l D PTS: i . l 1

, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e i.l i.l i.l i.l Ch02


Chapter 2. Review of Basic Principles of Pharmacology
i.l i.l i.l i.l i.l i.l i.l




MULTIPLE CHOICE i.l




1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



criticalto prescribing because:
i.l i.l i.l i.l



A. Distribution of drugs to target tissue may be affected. i.l i.l i.l i.l i.l i.l i.l i.l



B. The solubility of the drug will not match the site of absorption.
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



C. There will be less free drug available to generate an effect. i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



D. Drugs bound to albumin are readily excreted by the kidneys. i.l i.l i.l i.l i.l i.l i.l i.l i.l




ANS: i . l A PTS: i . l 1

2. Drugs that have a significant first-pass effect:
i.l i.l i.l i.l i.l i.l



A. Must be given by the enteral (oral) route only i.l i.l i.l i.l i.l i.l i.l i.l



B. Bypass the hepatic circulation i.l i.l i.l



C. Are rapidly metabolized by the liver and may have little, if any, desired action
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



D. Are converted by the liver to more active and fat-soluble forms
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l




ANS: i . l C PTS: i . l 1

3. The route of excretion of a volatile drug will likely be the:
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



A. Kidneys
B. Lungs
C. Bile and feces i.l i.l



D. Skin
ANS: i . l B PTS: i . l 1

4. A major disadvantage to IV administration is that:
i.l i.l i.l i.l i.l i.l i.l



A. First-pass metabolism is eliminated. i.l i.l i.l



B. Needles and sterility are required. i.l i.l i.l i.l



C. Absorption of the drug cannot be slowed after administration. i.l i.l i.l i.l i.l i.l i.l i.l



D. It is significantly more expensive than other routes.
i.l i.l i.l i.l i.l i.l i.l




ANS: i . l C PTS: i.l i.l i . l 1

5. The nurse practitioner (NP) chooses to give cephalexin every 8 hours based on knowledge
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



i.l ofthe drug’s:
i.l i.l



A. Propensity to go to the target receptor i.l i.l i.l i.l i.l i.l



B. Biological half-life i.l



C. Pharmacodynamics
D. Safety and side effects i.l i.l i.l




ANS: i . l B PTS: i . l 1

6. Deferasirox is a chelating agent used to treat iron overload by binding iron to render i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



i.l itbiologically inactive. This is best characterized as a(n):
i.l i.l i.l i.l i.l i.l i.l i.l

, Woo 2
Pharmacotherapeutics for APN Prescribers, 6e i.l i.l i.l i.l Ch02


A. Nonreceptor mechanism i.l



B. Partial agonist i.l



C. Full agonist i.l



D. Noncompetitive antagonist i.l




ANS: i . l A PTS: i . l 1

7. The point in time on the drug concentration curve that indicates the first sign of a
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



therapeuticeffect is the:
i.l i.l i.l i.l



A. Minimum adverse effect level i.l i.l i.l



B. Peak of action i.l i.l



C. Onset of action i.l i.l



D. Therapeutic range i.l




ANS: i . l C PTS: i . l 1

8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



A. When the drug has a wide therapeutic range i.l i.l i.l i.l i.l i.l i.l



B. When the drug will be administered for a short time only i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



C. When there is a high correlation between the dose and saturation of receptor sites
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



D. To determine if a drug is in the therapeutic range
i.l i.l i.l i.l i.l i.l i.l i.l i.l




ANS: i . l D PTS: i . l 1

9. A laboratory result indicates that the peak level for a drug is above the minimum
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



toxicconcentration. This means that the:
i.l i.l i.l i.l i.l i.l



A. Concentration will produce therapeutic effects. i.l i.l i.l i.l



B. Concentration will produce an adverse response. i.l i.l i.l i.l i.l



C. Time between doses must be shortened. i.l i.l i.l i.l i.l



D. Duration of action of the drug is too long. i.l i.l i.l i.l i.l i.l i.l i.l




ANS: i . l B PTS: i . l 1

10. Drugs that are receptor agonists may demonstrate what property?
i.l i.l i.l i.l i.l i.l i.l i.l



A. Irreversible binding to the drug receptor site i.l i.l i.l i.l i.l i.l



B. Up-regulation with chronic use i.l i.l i.l



C. Desensitization or down-regulation with continuous use i.l i.l i.l i.l i.l



D. Inverse relationship between drug concentration and drug action i.l i.l i.l i.l i.l i.l i.l




ANS: i . l C PTS: i . l 1

11. Drugs that are receptor antagonists, such as beta blockers, may cause:
i.l i.l i.l i.l i.l i.l i.l i.l i.l i.l



A. Down-regulation of the drug receptor i.l i.l i.l i.l



B. An exaggerated response if abruptly discontinued
i.l i.l i.l i.l i.l



C. Partial blockade of the effects of agonist drugs i.l i.l i.l i.l i.l i.l i.l



D. An exaggerated response to competitive drug agonists
i.l i.l i.l i.l i.l i.l




ANS: i . l B PTS: i . l 1

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller DREAMS. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$25.77. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

72042 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Recently viewed by you

Exam (elaborations) ·

(0)

Objective WGU C100 Exam Questions & Answers 2024/2025

CA$25.77  1x  sold
  • (0)
  Add to cart